| 0.693 0.098 (16.43%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.84 |
1-year : | 0.98 |
| Resists | First : | 0.71 |
Second : | 0.84 |
| Pivot price | 0.55 |
|||
| Supports | First : | 0.51 |
Second : | 0.38 |
| MAs | MA(5) : | 0.61 |
MA(20) : | 0.55 |
| MA(100) : | 0.56  |
MA(250) : | 0.76 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 84.1 |
D(3) : | 82.5 |
| RSI | RSI(14): 72.8 |
|||
| 52-week | High : | 1.78 | Low : | 0.37 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ OSRH ] has closed above the upper band by 17.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 8.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.72 - 0.72 | 0.72 - 0.73 |
| Low: | 0.58 - 0.58 | 0.58 - 0.58 |
| Close: | 0.69 - 0.69 | 0.69 - 0.7 |
OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Wed, 22 Apr 2026
Joint Protein Central (OSRH) files Schedule 13G reporting 7.9% ownership - Stock Titan
Wed, 22 Apr 2026
OSR Holdings appoints Yeiseok Kim as chief operating officer - Investing.com
Wed, 22 Apr 2026
OSR Holdings appoints Yeiseok Kim as Chief Operating Officer - TradingView
Wed, 22 Apr 2026
Yeiseok Kim appointed COO at OSR Holdings (NASDAQ: OSRH) - Stock Titan
Thu, 09 Apr 2026
OSR Holdings Eliminates $2M Warrant Overhang with New Note - ACCESS Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 1.53e+007 (%) |
| Held by Institutions | 36.2 (%) |
| Shares Short | 264 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.03e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 674.8 % |
| Return on Equity (ttm) | -6.7 % |
| Qtrly Rev. Growth | 2.91e+006 % |
| Gross Profit (p.s.) | -98.82 |
| Sales Per Share | -33.94 |
| EBITDA (p.s.) | 942627 |
| Qtrly Earnings Growth | -1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 0.14 |
| Dividend | 0 |
| Forward Dividend | 916510 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|